Inibidores
Showing 2881–2940 of 9073 results
-
Lumicitabine, TargetMol, #TQ0034-25mg (CAS:1445385-02-3)
Read more -
Fulacimstat, TargetMol, #TQ0035-10mg (CAS:1488354-15-9)
Read more -
Anemarrhenasaponin I, TargetMol, #TQ0036-25mg (CAS:163047-21-0)
Read more -
Abrocitinib, TargetMol, #TQ0037-10mg (CAS:1622902-68-4)
Read more -
AZD7986, TargetMol, #TQ0038-2mg (CAS:1802148-05-5)
Read more -
(±)-Zanubrutinib, TargetMol, #TQ0039-10mg (CAS:1633350-06-7)
Read more -
ONO-8590580, TargetMol, #TQ0040-10mg (CAS:1802661-73-9)
Read more -
Ningetinib Tosylate, TargetMol, #TQ0041-25mg (CAS:1394820-77-9)
Read more -
BAY-1436032, TargetMol, #TQ0042-25mg (CAS:1803274-65-8)
Read more -
Dofequidar, TargetMol, #TQ0043-50mg (CAS:129716-58-1)
Read more -
Seletalisib, TargetMol, #TQ0044-10mg (CAS:1362850-20-1)
Read more -
2-Hydroxy atorvastatin calcium salt, TargetMol, #TQ0045-50mg (CAS:265989-46-6)
Read more -
Bavisant, TargetMol, #TQ0046-10mg (CAS:929622-08-2)
Read more -
DG051, TargetMol, #TQ0047-2mg (CAS:929915-58-2)
Read more -
BI-882370, TargetMol, #TQ0048-25mg (CAS:1392429-79-6)
Read more -
MC-DOXHZN hydrochloride, TargetMol, #TQ0049-25mg (CAS:480998-12-7)
Read more -
NCGC00244536, TargetMol, #TQ0050-10mg (CAS:2003260-55-5)
Read more -
MK-7246, TargetMol, #TQ0051-10mg (CAS:1218918-62-7)
Read more -
SH5-07, TargetMol, #TQ0052-5mg (CAS:1456632-41-9)
Read more -
CYC065, TargetMol, #TQ0053-10mg (CAS:1070790-89-4)
Read more -
Purpureaside C, TargetMol, #TQ0054-25mg (CAS:108648-07-3)
Read more -
AMG-3969, TargetMol, #TQ0055-5mg (CAS:1361224-53-4)
Read more -
Cefuracetime, TargetMol, #TQ0056-10mg (CAS:39685-31-9)
Read more -
AVE 0991, TargetMol, #TQ0057-10mg (CAS:304462-19-9)
Read more -
MI-463, TargetMol, #TQ0058-10mg (CAS:1628317-18-9)
Read more -
Ilorasertib, TargetMol, #TQ0059-25mg (CAS:1227939-82-3)
Read more -
LY2857785, TargetMol, #TQ0060-10mg (CAS:1619903-54-6)
Read more -
CHZ868, TargetMol, #TQ0061-25mg (CAS:1895895-38-1)
Read more -
Nastorazepide, TargetMol, #TQ0062-5mg (CAS:209219-38-5)
Read more -
Zoliflodacin, TargetMol, #TQ0063-10mg (CAS:1620458-09-4)
Read more -
Peretinoin, TargetMol, #TQ0064-5mg (CAS:81485-25-8)
Read more -
Pseudobufarenogin, TargetMol, #TQ0065-10mg (CAS:17008-69-4)
Read more -
GSK189254A, TargetMol, #TQ0066-10mg (CAS:720690-73-3)
Read more -
GSK484 hydrochloride, TargetMol, #TQ0067-25mg (CAS:1652591-81-5)
Read more -
NVP-LCQ195, TargetMol, #TQ0068-10mg (CAS:902156-99-4)
Read more -
MI-503, TargetMol, #TQ0069-25mg (CAS:1857417-13-0)
Read more -
Luteolin-3-O-beta-D-glucuronide, TargetMol, #TQ0070-10mg (CAS:53527-42-7)
Read more -
Navoximod, TargetMol, #TQ0071-5mg (CAS:1402837-78-8)
Read more -
Warangalone, TargetMol, #TQ0072-5mg (CAS:4449-55-2)
Read more -
Andropanolide, TargetMol, #TQ0073-1mg (CAS:869807-57-8)
Read more -
ACY-775, TargetMol, #TQ0074-25mg (CAS:1375466-18-4)
Read more -
ML314, TargetMol, #TQ0075-25mg (CAS:1448895-09-7)
Read more -
KIRA6, TargetMol, #TQ0076-50mg (CAS:1589527-65-0)
Read more -
Ceftobiprole, TargetMol, #TQ0077-10mg (CAS:209467-52-7)
Read more -
CDK inhibitor II, TargetMol, #TQ0078-50mg (CAS:1269815-17-9)
Read more -
GNE-495, TargetMol, #TQ0079-25mg (CAS:1449277-10-4)
Read more -
SU14813 maleate, TargetMol, #TQ0080-50mg (CAS:849643-15-8)
Read more -
JPH203, TargetMol, #TQ0081-100mg (CAS:1037592-40-7)
Read more -
Aticaprant, TargetMol, #TQ0082-5mg (CAS:1174130-61-0)
Read more -
NI-57, TargetMol, #TQ0083-50mg (CAS:1883548-89-7)
Read more -
lumateperone Tosylate, TargetMol, #TQ0084-50mg (CAS:1187020-80-9)
Read more -
Presatovir, TargetMol, #TQ0085-10mg (CAS:1353625-73-6)
Read more -
AF38469, TargetMol, #TQ0086-50mg (CAS:1531634-31-7)
Read more -
NKP608, TargetMol, #TQ0087-100mg (CAS:177707-12-9)
Read more -
Exatecan Mesylate, TargetMol, #TQ0088-50mg (CAS:169869-90-3)
Read more -
Juglanin, TargetMol, #TQ0089-5mg (CAS:5041-67-8)
Read more -
Nesbuvir, TargetMol, #TQ0090-10mg (CAS:691852-58-1)
Read more -
LY2795050, TargetMol, #TQ0091-50mg (CAS:1346133-08-1)
Read more -
Naquotinib, TargetMol, #TQ0092-10mg (CAS:1448232-80-1)
Read more -
JNJ-40411813, TargetMol, #TQ0094-25mg (CAS:1127498-03-6)
Read more